Skip to main content
Log in

Beitrag zum Einfluß von Zymosan auf das tierexperimentelle Tumorwachstum

  • Published:
Zeitschrift für Krebsforschung Aims and scope Submit manuscript

Summary

20 mg Zymosan/kg body weight intravenously injected to rats implanted with Jensen-sarcoma and Walker-carcinoma retard the tumour growth. It seems that Zymosan aits on tumour growth by in fluencing the properdin level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  • Bradner, W. T., D. A. Clarke and C. C. Stock: Proc. Amer. Ass. Cancer Res. 2, 191 (1957).

    Google Scholar 

  • Pillemer, L., L. Blum, I. Lepow, L. Wurz and E. W. Todd: III. The Zymosan Assay of Properdin. J. exp. Med. 103, 1 (1956).

    Google Scholar 

  • Warburg, O.: Über den Stoffwechsel der Tumoren. Berlin 1926.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lührs, W., Heise, E. & Berndt, H. Beitrag zum Einfluß von Zymosan auf das tierexperimentelle Tumorwachstum. Z Krebs-forsch 62, 516–518 (1958). https://doi.org/10.1007/BF00525477

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00525477

Navigation